Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAurinia Pharmaceuticals Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | $0.09 | $0.10 | $0.10 |
| Q2 2025 | 1 | $0.10 | $0.11 | $0.11 |
| Q3 2025 | 1 | $0.12 | $0.12 | $0.12 |
| Q4 2025 | 1 | $0.12 | $0.12 | $0.12 |
Aurinia Pharmaceuticals Inc. Earnings Date And Information
Aurinia Pharmaceuticals Inc. last posted its earnings results on Thursday, February 27th, 2025. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.03 by $0.06. The company had revenue of 59.87 M for the quarter and had revenue of 235.13 M for the year. Aurinia Pharmaceuticals Inc. has generated $0 earnings per share over the last year ($0.0393 diluted earnings per share) and currently has a price-to-earnings ratio of 201.45. Aurinia Pharmaceuticals Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based on prior year's report dates.
Aurinia Pharmaceuticals Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/27/2025 | Q4 2024 | $0.03 | $0.01 | -0.02 | $60.11 M | $59.87 M |
| 11/07/2024 | Q3 2024 | $0.02 | $0.10 | 0.09 | $57.48 M | $67.77 M |
| 08/01/2024 | Q2 2024 | $0.02 | $0.01 | -0.01 | $54.25 M | $57.19 M |
| 05/02/2024 | Q1 2024 | -$0.17 | -$0.07 | 0.1 | N/A | $50.30 M |
| 04/29/2024 | Q4 2023 | N/A | -$0.19 | N/A | $45.00 M | $45.10 M |
| 11/02/2023 | Q3 2023 | -$0.17 | -$0.09 | 0.08 | $38.44 M | $54.52 M |
| 08/03/2023 | Q2 2023 | -$0.20 | -$0.08 | 0.12 | $37.90 M | $41.49 M |
| 05/04/2023 | Q1 2023 | -$0.24 | -$0.18 | 0.06 | N/A | $34.41 M |
| 02/28/2023 | Q4 2022 | -$0.26 | -$0.18 | 0.08 | N/A | $28.44 M |
| 11/03/2022 | Q3 2022 | -$0.18 | -$0.06 | 0.12 | $36.19 M | $55.78 M |
| 08/04/2022 | Q2 2022 | -$0.22 | -$0.25 | -0.03 | $27.04 M | $28.19 M |
| 05/10/2022 | Q1 2022 | -$0.26 | -$0.27 | -0.01 | N/A | $21.63 M |
| 02/28/2022 | Q4 2021 | -$0.26 | -$0.25 | 0.01 | N/A | $23.40 M |
| 11/03/2021 | Q3 2021 | -$0.31 | -$0.39 | -0.08 | $13.87 M | $14.67 M |
| 08/05/2021 | Q2 2021 | -$0.35 | -$0.37 | -0.02 | $4.96 M | $6.62 M |
| 05/06/2021 | Q1 2021 | -$0.35 | -$0.40 | -0.05 | N/A | $914,000 |
| 02/24/2021 | Q4 2020 | -$0.31 | -$0.06 | 0.25 | N/A | $50.03 M |
| 09/29/2020 | Q3 2020 | N/A | -$0.28 | N/A | $43,429 | $29,000 |
| 07/21/2020 | Q2 2020 | N/A | -$0.26 | N/A | $27,556 | $29,000 |
| 04/20/2020 | Q1 2020 | -$0.20 | -$0.15 | 0.05 | N/A | $30,000 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aurinia Pharmaceuticals Inc. Earnings: FAQ's
Aurinia Pharmaceuticals Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 13th, 2025 based offlast year's report dates.
In the previous quarter, Aurinia Pharmaceuticals Inc. (:AUPH) reported $0.09 earnings per share (EPS) to beat the analysts' consensus estimate of $0.03 by $0.06.
The conference call for Aurinia Pharmaceuticals Inc.'s latest earnings report can be listened to online.
The conference call transcript for Aurinia Pharmaceuticals Inc.'s latest earnings report can be read online.
Aurinia Pharmaceuticals Inc. (:AUPH) has a recorded annual revenue of $235.13 M.
Aurinia Pharmaceuticals Inc. (:AUPH) has a recorded net income of $5.75 M.Aurinia Pharmaceuticals Inc. has generated $0.0402 earnings per share over the last four quarters.
Aurinia Pharmaceuticals Inc. (:AUPH) has a price-to-earnings ratio of 201.45 and price/earnings-to-growth ratio is 1.61.